NeuroSense Net Income vs Other Operating Expenses Analysis
| NRSNW Stock | USD 0.24 0.06 20.00% |
NeuroSense Therapeutics financial indicator trend analysis is infinitely more than just investigating NeuroSense Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroSense Therapeutics is a good investment. Please check the relationship between NeuroSense Therapeutics Net Income and its Other Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroSense Therapeutics Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy NeuroSense Stock please use our How to Invest in NeuroSense Therapeutics guide.
Net Income vs Other Operating Expenses
Net Income vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroSense Therapeutics Net Income account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between NeuroSense Therapeutics' Net Income and Other Operating Expenses is -0.96. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of NeuroSense Therapeutics Ltd, assuming nothing else is changed. The correlation between historical values of NeuroSense Therapeutics' Net Income and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of NeuroSense Therapeutics Ltd are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Net Income i.e., NeuroSense Therapeutics' Net Income and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.96 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in NeuroSense Therapeutics financial statement analysis. It represents the amount of money remaining after all of NeuroSense Therapeutics Ltd operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of NeuroSense Therapeutics. It is also known as NeuroSense Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most indicators from NeuroSense Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroSense Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroSense Therapeutics Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy NeuroSense Stock please use our How to Invest in NeuroSense Therapeutics guide.Enterprise Value is likely to climb to about 12.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.3 M in 2024.
NeuroSense Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
NeuroSense Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NeuroSense Stock Analysis
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.